PT Merck Tbk (IDX:MERK)
4,040.00
+60.00 (1.51%)
May 22, 2026, 3:48 PM WIB
PT Merck Tbk Revenue
PT Merck Tbk had revenue of 283.11B IDR in the quarter ending March 31, 2026, with 31.58% growth. This brings the company's revenue in the last twelve months to 1.27T, up 26.56% year-over-year. In the year 2025, PT Merck Tbk had annual revenue of 1.20T with 15.81% growth.
Revenue (ttm)
1.27T
Revenue Growth
+26.56%
P/S Ratio
1.43
Revenue / Employee
3.50B
Employees
362
Market Cap
1.81T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.20T | 163.92B | 15.81% |
| Dec 31, 2024 | 1.04T | 75.31B | 7.83% |
| Dec 31, 2023 | 961.43B | -163.17B | -14.51% |
| Dec 31, 2022 | 1.12T | 60.20B | 5.66% |
| Dec 31, 2021 | 1.06T | 408.55B | 62.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 36.21T |
| PT Medela Potentia Tbk | 15.03T |
| PT Siloam International Hospitals Tbk | 13.09T |
| PT Kimia Farma Tbk | 9.09T |
| PT Mitra Keluarga Karyasehat Tbk | 5.45T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.64T |
| PT Prodia Widyahusada Tbk | 2.30T |
| PT Darya-Varia Laboratoria Tbk | 2.28T |